Medication info
Paramet Duo Tablet 20/700mg (Rabeprazole Sodium, Sodium Bicarbonate)

Paramet Duo Tablet 20/700mg (Rabeprazole Sodium, Sodium Bicarbonate)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›20mg / 1 tabletSodium Bicarbonate›700mg / 1 tablet
Manufacturer / importer
Hana Pharmaceutical Co., Ltd.
Appearance
Pale pink oval film-coated tablet
Packaging
28 tablets/bottle
Approval status
Active

MFDS item code 202402104 · Approved 2024.08.30 · Insurance code 657808260

Summary

Main use
Treatment, symptom relief, and long-term maintenance of gastroesophageal reflux disease; treatment of peptic ulcers
Who takes it
Adults · Children
Adult dose
Although this medicine 10/700mg and 20/700mg contain 10 mg and 20 mg of rabeprazole sodium, respectively, note that the amount of sodium bicarbonate in two tablets of this medicine 10/700mg is not the same as that in one tablet of 20/700mg. 1) Gastric ulcer, duodenal ulcer: The usual adult dose is 10/700 mg orally once daily. Depending on symptoms, 20/700 mg may be administered orally once daily. Treatment is generally continued for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. 2) Erosive or ulcerative gastroesophageal reflux disease: Administer 10/700 mg or 20/700 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10/700 mg or 20/700 mg may be administered orally twice daily for an additional 8 weeks. However, the 20/700 mg twice-daily regimen is limited to patients with confirmed severe mucosal damage. 3) Relief of symptoms of gastroesophageal reflux disease: Administer 10/700mg once daily. If symptoms are not controlled after 4 weeks of treatment, further medical evaluation is necessary. After symptoms resolve, subsequent symptoms may be controlled, as needed, using on-demand therapy with 10/700mg once daily. 4) Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10/700mg or 20/700 mg orally once daily, depending on the patient. Patients with hepatic impairment: Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Patients with renal impairment: The safety and efficacy in patients with renal impairment have not been established. Use with caution because there is no experience with this medicine in these patients. Elderly patients: Administer with caution because hepatic function is often reduced.
Child dose
Safety has not been established in pediatric patients.

Ingredients

Manufacturer
Hana Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment, symptom relief, and long-term maintenance of gastroesophageal reflux disease; treatment of peptic ulcers

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
View approved original text

This medication is used to treat ulcers in the digestive system, such as gastric ulcers and duodenal ulcers. It is also effective for erosive or ulcerative gastroesophageal reflux disease, helping to relieve symptoms caused by this condition. It is applicable for long-term maintenance therapy of gastroesophageal reflux disease to contribute to preventing recurrence. Therefore, it is widely used for the treatment of various ulcers and reflux diseases of the digestive tract.

How to take

Adult dose

Although this medicine 10/700mg and 20/700mg contain 10 mg and 20 mg of rabeprazole sodium, respectively, note that the amount of sodium bicarbonate in two tablets of this medicine 10/700mg is not the same as that in one tablet of 20/700mg. 1) Gastric ulcer, duodenal ulcer: The usual adult dose is 10/700 mg orally once daily. Depending on symptoms, 20/700 mg may be administered orally once daily. Treatment is generally continued for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. 2) Erosive or ulcerative gastroesophageal reflux disease: Administer 10/700 mg or 20/700 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10/700 mg or 20/700 mg may be administered orally twice daily for an additional 8 weeks. However, the 20/700 mg twice-daily regimen is limited to patients with confirmed severe mucosal damage. 3) Relief of symptoms of gastroesophageal reflux disease: Administer 10/700mg once daily. If symptoms are not controlled after 4 weeks of treatment, further medical evaluation is necessary. After symptoms resolve, subsequent symptoms may be controlled, as needed, using on-demand therapy with 10/700mg once daily. 4) Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10/700mg or 20/700 mg orally once daily, depending on the patient. Patients with hepatic impairment: Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Patients with renal impairment: The safety and efficacy in patients with renal impairment have not been established. Use with caution because there is no experience with this medicine in these patients. Elderly patients: Administer with caution because hepatic function is often reduced.

Child dose

Safety has not been established in pediatric patients.

Precautions

This medication contains Rabeprazole Sodium and Sodium Bicarbonate, which work to inhibit gastric acid secretion. This medication should not be used in patients with allergies to Rabeprazole or benzimidazole derivatives, those taking specific antiviral drugs such as Atazanavir or Lopinavir, and women who are pregnant or breastfeeding. Patients with liver or kidney impairments, the elderly, those with weak heart or lung function, and patients with electrolyte imbalances should use this medication cautiously, especially those who need to restrict sodium intake. Various adverse reactions such as skin rash, itching, blood anomalies, liver dysfunction, heart issues, gastrointestinal symptoms, neurological symptoms, respiratory problems, muscle and joint pain may occur during the use of this medication, so immediate consultation with a doctor should be sought if any symptoms arise. Long-term use should include regular blood tests and liver function tests, as absorption disorders of vitamin B12 or increased fracture risk may occur. This medication can reduce gastric acid, promoting bacterial growth in the gastrointestinal tract, increasing the risk of diarrhea or gastrointestinal infections; thus, medical consultation is recommended if symptoms persist. Caution is necessary when driving or operating machinery due to the possibility of drowsiness. There may be potential interactions with other drugs, so it is advisable to consult a doctor or pharmacist, especially if using together with warfarin, methotrexate, ketoconazole, digoxin, etc. There is no specific antidote for overdose; treatment based on symptoms is necessary, so immediate medical attention should be sought. Keep out of reach of children and do not store in a different container for safety. It is safer not to use this medication during pregnancy or breastfeeding, and caution is advised for the elderly due to potential adverse reactions from impaired liver function. Safety in children has not been established, and there is no experience in use.

Side effects

Rash, urticaria, itching, erythrocytopenia, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphocytopenia, anemia, petechiae, lymphadenopathy, hypoplastic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, ALT elevation, AST elevation, ALP elevation, γ-GTP elevation, LDH elevation, total bilirubin elevation, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, ECG abnormality, migraine, syncope, angina pectoris, heart block, palpitations, tachycardia, bradycardia, pulmonary embolism, ventricular tachycardia, thrombophlebitis, vasodilation, QTc prolongation, ventricular fibrillation, diarrhea, constipation, abdominal pain, abdominal bloating, dyspepsia, belching, nausea, rectal bleeding, blood in stool, anorexia, cholelithiasis, oral ulcer, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stool, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric contents, gastritis, stomatitis, dysgeusia, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, salivary gland enlargement, thirst, headache, insomnia, anxiety, dizziness, seizures, abnormal dreams, decreased libido, neuropathy, sensory disturbances, tremors, weakness, hyperesthesia, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, hypervolemia, limb weakness, sensory dullness, grip strength reduction, speech confusion, staggering, delirium, disorientation, hypersomnia, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, low back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, muscle hypertonicity, neuralgia, single contraction, sweating, alopecia, skin dryness, herpes zoster, psoriasis, skin color change, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataracts, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacity, blurred vision, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequent urination, dysmenorrhea, urinary obstruction, nephrolithiasis, uterine bleeding, polyuria, gynecomastia, elevated total cholesterol, elevated triglycerides, elevated BUN, increased serum thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, fatigue, weight gain, visual disturbances, loss of appetite, neck stiffness, photosensitivity reaction, hangover effect, weight loss, gout, anaphylactic reaction, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, disorientation, delirium, vascular edema, hypomagnesemia, thrombocytopenia, neutropenia, agranulocytosis, pancytopenia, vesicular skin rash, urticarial skin rash, systemic allergic reaction, myalgia, arthralgia, interstitial nephritis, gynecomastia, elevated thyroid-stimulating hormone, bone fracture, gastric polyp, Clostridium difficile colitis, systemic lupus erythematosus, cutaneous lupus erythematosus, halitosis, dry mouth, chest tightness, allergic reaction, hypertriglyceridemia, hypercholesterolemia, palpitations, increased intraocular pressure

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a sealed container, unaffected by air or humidity. It is important to maintain a storage temperature of 1 to 30 degrees Celsius at room temperature. This helps to preserve the efficacy and safety of the medication over a long time.

Appearance and packaging

Appearance

Pale pink oval film-coated tablet

Package unit

28 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.